Muñoz-Basagoiti J, Pérez-Zsolt D, León R, Blanc V, Gispert J, Clotet B, Izquierdo-Useros
I. Cetylpyridinium chloride-containing mouthwashes reduce in vitro SARS-CoV-2 infectivity.
bioRxiv 2020.12.21.423779; [preprint] doi: https://doi.org/10.1101/2020.12.21.423779
Komine A, Yamaguchi E, Okamoto N, Yamamoto K. Virucidal activity of oral care products
against SARS-CoV-2 in vitro. J Oral Maxillofac Surg Med Pathol. 2021 Feb 22. doi:
10.1016/j.ajoms.2021.02.002.
Ellinger B, Bojkova D, Zaliani A, Cinatl J, Claussen C, Westhaus S, Keminer O, Reinshagen
J, Kuzikov M, Wolf M, Geisslinger G, Gribbon P, Ciesek S. A SARS-CoV-2 cytopathicity
dataset generated by high-content screening of a large drug repurposing collection. Sci
Data. 2021 Feb 26;8(1):70. doi: 10.1038/s41597-021-00848-4.
Seneviratne CJ, Balan P, Ko KKK, Udawatte NS, Lai D, Ng DHL, Venkatachalam I, Lim KS, Ling
ML, Oon L, Goh BT, Sim XYJ. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load
in saliva: randomized control trial in Singapore. Infection. 2020 Dec 14:1–7. doi:
10.1007/s15010-020-01563-9.
Koch-Heier J, Hoffmann H, Schindler M, Lussi A, Planz O. Inactivation of SARS-CoV-2
through Treatment with the Mouth Rinsing Solutions ViruProX® and BacterX® Pro.
Microorganisms. 2021; 9(3):521. https://doi.org/10.3390/microorganisms9030521.
Shen L, Niu J, Wang C, Huang B, Wang W, Zhu N, Deng Y, Wang H, ye F, Cen S, Tan W4. 2019.
High-Throughput Screening and Identification of Ponent Broad-Spectrum Inhibitors of
Coronaviruses. J Virol. 2019 May 29;93(12). pii: e00023-19. doi: 10.1128/JVI.00023-19.
Print 2019 Jun 15.
Popkin DL, Zilka S, Dimaano M, Fujioka H, Rackley C, Salata R et al. Cetylpyridinium
chloride (CPC) exhibits potent, rapid activity gainst influenza viruses in vitro and in
vivo. Pathogens and Immunity. 2017;2(2):253-69
Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MA et al. Randomized,
double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of
a novel dual-action oral topical formulation against upper respiratory infections. BMC
Infect Dis. 2017 Jan 14;17(1):74